1-1045444-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_198576.4(AGRN):​c.2457G>C​(p.Gly819Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00703 in 1,612,524 control chromosomes in the GnomAD database, including 176 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G819G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.021 ( 68 hom., cov: 33)
Exomes 𝑓: 0.0056 ( 108 hom. )

Consequence

AGRN
NM_198576.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.188

Publications

7 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 1-1045444-G-C is Benign according to our data. Variant chr1-1045444-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 190974.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.188 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0545 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.2457G>C p.Gly819Gly synonymous_variant Exon 14 of 36 ENST00000379370.7 NP_940978.2 O00468-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.2457G>C p.Gly819Gly synonymous_variant Exon 14 of 36 1 NM_198576.4 ENSP00000368678.2 O00468-6

Frequencies

GnomAD3 genomes
AF:
0.0205
AC:
3113
AN:
152222
Hom.:
68
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0563
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0106
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.0316
Gnomad SAS
AF:
0.00952
Gnomad FIN
AF:
0.0190
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00243
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0109
AC:
2707
AN:
249244
AF XY:
0.0102
show subpopulations
Gnomad AFR exome
AF:
0.0553
Gnomad AMR exome
AF:
0.00565
Gnomad ASJ exome
AF:
0.00571
Gnomad EAS exome
AF:
0.0269
Gnomad FIN exome
AF:
0.0198
Gnomad NFE exome
AF:
0.00300
Gnomad OTH exome
AF:
0.00886
GnomAD4 exome
AF:
0.00562
AC:
8210
AN:
1460184
Hom.:
108
Cov.:
34
AF XY:
0.00555
AC XY:
4031
AN XY:
726366
show subpopulations
African (AFR)
AF:
0.0579
AC:
1937
AN:
33472
American (AMR)
AF:
0.00595
AC:
266
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00547
AC:
143
AN:
26126
East Asian (EAS)
AF:
0.0299
AC:
1185
AN:
39686
South Asian (SAS)
AF:
0.00923
AC:
796
AN:
86244
European-Finnish (FIN)
AF:
0.0183
AC:
950
AN:
52006
Middle Eastern (MID)
AF:
0.0106
AC:
61
AN:
5768
European-Non Finnish (NFE)
AF:
0.00209
AC:
2320
AN:
1111808
Other (OTH)
AF:
0.00914
AC:
552
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
541
1081
1622
2162
2703
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0205
AC:
3126
AN:
152340
Hom.:
68
Cov.:
33
AF XY:
0.0210
AC XY:
1566
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0564
AC:
2346
AN:
41574
American (AMR)
AF:
0.0106
AC:
162
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00374
AC:
13
AN:
3472
East Asian (EAS)
AF:
0.0315
AC:
163
AN:
5182
South Asian (SAS)
AF:
0.00973
AC:
47
AN:
4828
European-Finnish (FIN)
AF:
0.0190
AC:
202
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00243
AC:
165
AN:
68024
Other (OTH)
AF:
0.0128
AC:
27
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
138
275
413
550
688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00299
Hom.:
1
Bravo
AF:
0.0206
EpiCase
AF:
0.00224
EpiControl
AF:
0.00261

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 28, 2016
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Dec 31, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Congenital myasthenic syndrome 8 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
2.3
DANN
Benign
0.30
PhyloP100
-0.19
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=85/15
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112039851; hg19: chr1-980824; COSMIC: COSV65068120; COSMIC: COSV65068120; API